We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+4.44%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$28.3B
AUM Growth
+$2.33B
(+9%)
Cap. Flow
+$1.79B
Cap. Flow
% of AUM
6.32%
Top 10 Holdings %
Top 10 Hldgs %
25.96%
Holding
1,069
New
128
Increased
377
Reduced
389
Closed
143
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arista Networks
ANET
|
+$356M |
| 2 |
Lam Research
LRCX
|
+$283M |
| 3 |
Palo Alto Networks
PANW
|
+$261M |
| 4 |
GE Vernova
GEV
|
+$216M |
| 5 |
Tractor Supply
TSCO
|
+$167M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amphenol
APH
|
+$275M |
| 2 |
Intuit
INTU
|
+$214M |
| 3 |
CrowdStrike
CRWD
|
+$204M |
| 4 |
Williams-Sonoma
WSM
|
+$164M |
| 5 |
Old Dominion Freight Line
ODFL
|
+$150M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.61% |
| 2 | Financials | 14.28% |
| 3 | Consumer Discretionary | 13.77% |
| 4 | Industrials | 12.88% |
| 5 | Healthcare | 9.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Lifecore Biomedical
LFCR
$165M
| – | – |
-42,074
| Closed | -$207K |
|
1002
Grand Canyon Education
LOPE
$3.99B
| – | – |
-13,799
| Closed | -$1.96M |
|
1003
Lowe's Companies
LOW
$122B
| – | – |
-757
| Closed | -$205K |
|
1004
Lexeo Therapeutics
LXEO
$345M
| – | – |
-30,346
| Closed | -$274K |
|
|
MAPS
1005
DELISTED
WM TECHNOLOGY INC A
MAPS
| – | – |
-86,599
| Closed | -$75.3K |
|
1006
908 Devices
MASS
$288M
| – | – |
-13,500
| Closed | -$46.8K |
|
1007
MDU Resources
MDU
$4.31B
| – | – |
-129,058
| Closed | -$1.96M |
|
1008
Mercer International
MERC
$45.6M
| – | – |
-337,028
| Closed | -$2.28M |
|
1009
3M
MMM
$94.1B
| – | – |
-24,678
| Closed | -$3.37M |
|
1010
Marathon Petroleum
MPC
$89.3B
| – | – |
-256,235
| Closed | -$41.7M |
|
1011
Marten Transport
MRTN
$1.25B
| – | – |
-38,730
| Closed | -$686K |
|
1012
Murphy Oil
MUR
$5.25B
| – | – |
-7,247
| Closed | -$245K |
|
1013
Navient
NAVI
$822M
| – | – |
-490,223
| Closed | -$7.64M |
|
1014
NOV
NOV
$7.11B
| – | – |
-17,119
| Closed | -$273K |
|
1015
Nextpower Inc
NXT
$14.5B
| – | – |
-96,978
| Closed | -$3.63M |
|
1016
Organon & Co
OGN
$3.55B
| – | – |
-1,242,135
| Closed | -$23.8M |
|
|
OLO
1017
DELISTED
Olo Inc
OLO
| – | – |
-429,133
| Closed | -$2.13M |
|
1018
Outset Medical
OM
$87.5M
| – | – |
-3,683
| Closed | -$37.4K |
|
1019
Ranpak Holdings
PACK
$550M
| – | – |
-14,171
| Closed | -$92.5K |
|
1020
Paycom
PAYC
$7.54B
| – | – |
-223,639
| Closed | -$37.3M |
|
1021
PACCAR
PCAR
$72.7B
| – | – |
-46,416
| Closed | -$4.58M |
|
1022
Penumbra
PEN
$12.6B
| – | – |
-1,565
| Closed | -$304K |
|
1023
Preferred Bank
PFBC
$1.25B
| – | – |
-11,065
| Closed | -$888K |
|
1024
Planet Labs
PL
$7.28B
| – | – |
-895,109
| Closed | -$2M |
|
1025
Protolabs
PRLB
$1.78B
| – | – |
-73,424
| Closed | -$2.16M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q4 2024 Portfolio in Review
As of Q4 2024, Jacobs Levy Equity Management held 1,069 positions worth $28.3B, up 9% from $25.9B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Jacobs Levy Equity Management deployed $1.79B of net new capital in Q4 2024, opening 128 new positions and adding to 377 existing holdings. Its largest new stake was Tractor Supply: 2,947,687 shares worth $156M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Amphenol, an estimated $275M trimmed.
- Jacobs Levy Equity Management's largest Q4 2024 buy was Tractor Supply: 2,947,687 shares worth $156M.
- Jacobs Levy Equity Management added most to Arista Networks in Q4 2024, an estimated $356M increase.
- Jacobs Levy Equity Management's biggest Q4 2024 reduction was Amphenol, cutting an estimated $275M.
- Jacobs Levy Equity Management fully exited Sarepta Therapeutics in Q4 2024, selling an estimated $94.1M.
- Jacobs Levy Equity Management's ten largest holdings make up 26% of its $28.3B portfolio in Q4 2024.
- Jacobs Levy Equity Management opened 128 new positions and closed 143 in Q4 2024.
- Jacobs Levy Equity Management's portfolio value rose 9% quarter-over-quarter to $28.3B.
Based on Jacobs Levy Equity Management's 13F filing for Q4 2024, filed 14 Feb 2025.